-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Achilles Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q2 2024.
- Achilles Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $1.31M, a 22.9% decline year-over-year.
- Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $6.36M, a 9.47% decline from 2022.
- Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $7.02M, a 11.2% increase from 2021.
- Achilles Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $6.32M, a 111% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)